EXPEDEON AG Inactive Instrument
Expedeon AG Share Price Deutsche Boerse AG
Equities
Investment Holding Companies
| Sales 2021 | - | Sales 2022 | 3.01M 3.22M 269M | Capitalization | 50.93M 54.45M 4.54B |
|---|---|---|---|---|---|
| Net income 2021 | -1M -1.07M -89.18M | Net income 2022 | -21M -22.45M -1.87B | EV / Sales 2021 | - |
| Net cash position 2021 | 42.85M 45.82M 3.82B | Net cash position 2022 | 17.42M 18.62M 1.55B | EV / Sales 2022 | 11.1 x |
| P/E ratio 2021 |
-39.9
x | P/E ratio 2022 |
-2.42
x | Employees | - |
| Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 19.23% |
More Fundamentals
* Assessed data
More news
More press releases
More news
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 53 | 09/19/09 | |
Sebastian Paul
ADM | Chief Administrative Officer | - | 01/15/01 |
Robert Mayer
IRC | Investor Relations Contact | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 53 | 09/19/09 | |
Eva Katheder
BRD | Director/Board Member | - | 28/21/28 |
Jochen Hummel
BRD | Director/Board Member | 54 | 03/22/03 |
2Invest AG, formerly 4Basebio AG, is a Germany-based investment company. 2invest AG acquires, holds, manages and sells investments in corporations and partnership in the biotechnology, life science and information technologies (IT) sectors in Germany and abroad.
Sector
Investment Holding Companies
Calendar
09/05/2024
- Q1 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| +16.54% | 75.59B | |
| +53.03% | 16.95B | |
| +3.20% | 15.78B | |
| +7.21% | 13.87B | |
| -0.77% | 12.3B | |
| +9.67% | 12.04B | |
| +6.24% | 10.88B | |
| +34.86% | 10.17B | |
| -1.71% | 9.7B |
